EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Managing Urticarial Vasculitis: A Clinical Decision-Making Algorithm Based on Expert Consensus

Nikolai Dario Rothermel, Carolina Vera Ayala, Margarida Gonçalo, Jie Shen Fok, Leonie Shirin Herzog, Emek Kocatürk, Sophia Neisinger, Manuel P Pereira, Indrashis Podder, Polina Pyatilova, Aiste Ramanauskaite, Melba Munoz und 4 weitere

American Journal of Clinical Dermatology · 2025-01 · 26 (1) · 61-75

DOI: 10.1007/s40257-024-00902-y ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift American Journal of Clinical Dermatology, online erschienen am 13.11.2024. Verfasst von Nikolai Dario Rothermel und 15 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Allergology, Charité - Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Hea…. Hauptthemen laut MEDLINE: Algorithms, Clinical Decision-Making, Vasculitis, Leukocytoclastic, Cutaneous, Urticaria. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Charité - Universitätsmedizin Berlin.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Urticarial vasculitis (UV) is a rare and difficult-to-treat, small-vessel leukocytoclastic vasculitis presenting with recurrent long-lasting wheals. So far, no guidelines and treatment algorithms exist that could help clinicians with the management of UV. In this review, we describe evidence on systemic treatments used for UV and propose a clinical decision-making algorithm for UV management based on the Urticarial Vasculitis Activity Score assessed for 7 days (UVAS7). Patients with occasional UV-like urticarial lesions and patients with UV with skin-limited manifestations and/or mild arthralgia/malaise (total UVAS7 ≤7 of 70) can be initially treated using the step-wise algorithm for chronic urticaria including second-generation H1-antihistamines, omalizumab, and cyclosporine A. Patients with UV with more severe symptoms (UVAS7 >7), especially those with hypocomplementemic UV, may require a multidisciplinary approach, particularly if underlying diseases, for example, systemic lupus erythematosus, cancer, or infection, are present. Immunomodulatory therapy is based on clinical signs and symptoms, and the drug availability and safety profile, and includes systemic corticosteroids, dapsone, hydroxychloroquine, anti-interleukin-1 agents, and other therapies. The level of evidence for all UV treatments is low. Prospective studies with current and novel drugs are needed and could provide further insights into UV pathogenesis and treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AlgorithmsClinical Decision-MakingVasculitis, Leukocytoclastic, CutaneousUrticariaHumansConsensusSeverity of Illness IndexPractice Guidelines as Topic

Autor:innen und Institutionen

  • Institute of Allergology, Charité - Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Hindenburgdamm 27, 12203, Berlin, Germany.
  • Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Immunology and Allergology, Berlin, Germany.
  • Dermatology, Faculty of Medicine, University of Coimbra, Coimbra, Portugal.
  • Dermatology Department, University Hospital, Coimbra Local Health Unit, Coimbra, Portugal.
  • Department of Respiratory Medicine and General Medicine, Box Hill Hospital, Eastern Health, Melbourne, VIC, Australia.
  • Monash Lung, Sleep and Allergy/Immunology, Monash Medical Centre, Melbourne, VIC, Australia.

Förderung

  • Charité - Universitätsmedizin Berlin

Zitieren

APA

Rothermel, N. D., Vera Ayala, C., Gonçalo, M., Fok, J. S., Herzog, L. S., Kocatürk, E., Neisinger, S., Pereira, M. P., Podder, I., Pyatilova, P., Ramanauskaite, A., Munoz, M., Krause, K., Maurer, M., Bonnekoh, H., & Kolkhir, P. (2025). Managing Urticarial Vasculitis: A Clinical Decision-Making Algorithm Based on Expert Consensus. American Journal of Clinical Dermatology, 26(1), 61-75. https://doi.org/10.1007/s40257-024-00902-y

Vancouver

Rothermel ND, Vera Ayala C, Gonçalo M, Fok JS, Herzog LS, Kocatürk E, et al. Managing Urticarial Vasculitis: A Clinical Decision-Making Algorithm Based on Expert Consensus. American Journal of Clinical Dermatology. 2025;26(1):61-75. doi:10.1007/s40257-024-00902-y

BibTeX
@article{Rothermel2025,
  author = {Rothermel, Nikolai Dario and Vera Ayala, Carolina and Gonçalo, Margarida and Fok, Jie Shen and Herzog, Leonie Shirin and Kocatürk, Emek and Neisinger, Sophia and Pereira, Manuel P and Podder, Indrashis and Pyatilova, Polina and Ramanauskaite, Aiste and Munoz, Melba and Krause, Karoline and Maurer, Marcus and Bonnekoh, Hanna and Kolkhir, Pavel},
  title = {Managing Urticarial Vasculitis: A Clinical Decision-Making Algorithm Based on Expert Consensus},
  journal = {American Journal of Clinical Dermatology},
  year = {2025},
  volume = {26},
  number = {1},
  pages = {61--75},
  doi = {10.1007/s40257-024-00902-y}
}
Kostenlos starten →